CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +15,000 | $2.03 | $30K | 493,888 |
| 2024-08-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −6,686 | $78.65 | $526K | 487,202 |
| 2024-08-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −8,314 | $79.25 | $659K | 478,888 |
| 2024-08-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 167,327 | ||
| 2024-08-19 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +8,000 | $5.35 | $43K | 104,720 |
| 2024-08-19 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −4,994 | $78.25 | $391K | 99,726 |
| 2024-08-19 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −3,006 | $79.14 | $238K | 96,720 |
| 2024-08-19 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 328,827 | ||
| 2024-08-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −2,977 | $78.84 | $235K | 207,526 |
| 2024-08-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −23 | $79.47 | $2K | 207,503 |
| 2024-08-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,308 | $78.80 | $103K | 142,130 |
| 2024-08-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,308 | $78.78 | $103K | 142,130 |
| 2024-08-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +1,667 | $21.41 | $36K | 32,493 |
| 2024-08-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −1,482 | $78.80 | $117K | 31,011 |
| 2024-08-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −185 | $79.29 | $15K | 30,826 |
| 2024-08-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise · Stock Option (right to buy) 10b5-1 | −1,667 | 181,664 | ||
| 2024-07-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +15,000 | $2.03 | $30K | 493,888 |
| 2024-07-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −5,718 | $83.83 | $479K | 488,170 |
| 2024-07-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −9,282 | $84.53 | $785K | 478,888 |
| 2024-07-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 182,327 |
Page 24 of 39 · 764 trades